Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016
Thu, January 14, 2016

Brian Abrahams Downgraded (SRPT) to Hold and Decreased Target to $15 on, Jan 19th, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. and-decreased-target-to-15-on-jan-19th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Brian Abrahams of RBC Capital, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $62 to $15 on, Jan 19th, 2016.

Brian has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joseph Schwartz of "Leerink Swann" Maintained at Hold with Decreased Target to $27 on, Friday, November 6th, 2015